重度肥胖成人肾移植可及性:基于人群的回顾性队列研究
该研究基于加拿大2000–2021年96,181例肾衰竭成人,评估中度或重度肥胖者接受肾移植的可能性及移植后结局。结果显示重度肥胖(BMI≥40)与中度肥胖(BMI 35.0–39.9)患者移植可能性显著低于对照组(BMI 18.5–24.9),风险比分别为0.43和0.76。移植后重度肥胖者移植物失败或死亡风险升高(HR 1.70),但幅度与其他常见临床特征相似。
要点
- 重度肥胖(BMI≥40)患者肾移植可能性仅为BMI 18.5–24.9者的43%。
- 中度肥胖(BMI 35.0–39.9)患者移植可能性为对照组的76%。
- 重度肥胖移植后移植物失败或死亡风险升高(HR 1.70),但幅度与其他常见特征相似。
核心结论
- 加拿大透析患者中中度或重度肥胖者接受肾移植的可能性显著降低。
- 重度肥胖者移植后移植物失败或死亡风险升高,但幅度与其他常见临床特征相似。
- 研究结果支持现行实践指南,建议识别并消除肥胖患者肾移植的障碍。
研究设计与样本
- 回顾性基于人群的队列研究,纳入2000至2021年间加拿大96,181例肾衰竭成人。
- 暴露因素为中度或重度肥胖及其他风险因素(如年龄组、糖尿病、心脏病)。
- 采用参数生存模型调整所有风险因素,中位随访2.5年。
主要发现
- 中位随访2.5年期间,58.2%患者死亡,16.3%接受移植。
- 重度肥胖(BMI≥40 kg/m2)者移植可能性低于对照组(BMI 18.5-24.9 kg/m2),HR 0.43(95% CI 0.39-0.47)。
- 中度肥胖(BMI 35.0-39.9 kg/m2)者移植可能性低于对照组,HR 0.76(95% CI 0.71-0.82)。
- 在39项特征/类别中,仅≥80岁者移植可能性低于重度肥胖者。
- 移植受者中位随访5.4年,重度肥胖者移植物失败或死亡风险高于对照组,HR 1.70(95% CI 1.38-2.02)。
关键数值与推荐
- 重度肥胖定义为BMI≥40 kg/m2,中度肥胖定义为BMI 35.0-39.9 kg/m2。
- 对照组为BMI 18.5-24.9 kg/m2。
- 重度肥胖者移植可能性HR 0.43(95% CI 0.39-0.47),中度肥胖者HR 0.76(95% CI 0.71-0.82)。
- 重度肥胖者移植后移植物失败或死亡HR 1.70(95% CI 1.38-2.02)。
临床怎么用
- 临床实践中应关注中度或重度肥胖肾衰竭患者接受肾移植的障碍。
- 对于重度肥胖患者,需权衡移植后移植物失败或死亡风险与其他常见临床特征的风险。
- 年轻、合并症少的中度或重度肥胖患者移植后风险可能低于其他常见临床特征者。
局限性
- 存在残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: International guidelines do not consider moderate or severe obesity to be a contraindication to kidney transplantation, but clinical practice suggests otherwise. This study evaluated the likelihood of kidney transplantation in patients with moderate or severe obesity and how that likelihood compared with patients with other risk factors. STUDY DESIGN: Retrospective population-based cohort study. SETTING & PARTICIPANTS: 96,181 adults with kidney failure, living in Canada between 2000 and 2021. EXPOSURE: Moderate or severe obesity and other risk factors (eg, age groups, diabetes, heart disease). OUTCOME: Time to transplantation and time to allograft failure or death. ANALYTICAL APPROACH: Parametric survival modeling, adjusting for all risk factors. RESULTS: Over a median follow-up period of 2.5 years, 58.2% of patients died, and 16.3% were transplanted. Participants with severe (body mass index [BMI] ≥ 40 kg/m2) or moderate (BMI 35.0-39.9 kg/m2) obesity were less likely to be transplanted than the control participants (BMI 18.5-24.9 kg/m2) (HR, 0.43 [95% CI, 0.39-0.47] and HR, 0.76 [95% CI, 0.71-0.82], respectively). Of 39 characteristics/categories considered, only participants aged ≥80 years were less likely to receive a transplant than those with severe obesity. Transplant recipients were followed for a median of 5.4 years. After those aged ≥65 years, participants with severe obesity were the most likely to experience allograft failure or death (HR, 1.70 [95% CI, 1.38-2.02] compared with controls). When we considered combinations of key risk factors, young participants with severe or moderate obesity and few comorbidities were at lower risk for allograft failure or death than participants with other common clinical characteristics. LIMITATIONS: Residual confounding. CONCLUSIONS: Canadian dialysis patients with moderate or severe obesity had a markedly reduced likelihood of receiving a kidney transplant. Although patients with moderate or severe obesity also had a heightened risk of allograft failure or death, the magnitude of the latter was similar to the excess risk associated with other common clinical characteristics. These findings support current practice guidelines and suggest that further work should identify and remove barriers to accessing kidney transplantation among patients with obesity. PLAIN-LANGUAGE SUMMARY: International guidelines do not consider moderate or severe obesity (body mass index ≥35 and ≥40 kg/m2, respectively) to be a contraindication to kidney transplantation, but clinical practice suggests otherwise. Canadian dialysis patients with moderate or severe obesity had a reduced likelihood of receiving a kidney transplant (24% and 57%, respectively). Although patients with moderate or severe obesity also had a heightened risk of allograft failure or death (36% and 70%, respectively), the magnitude of the latter was similar to the excess risk associated with other common clinical characteristics that do not exclude a patient from kidney transplantation. These findings support current practice guidelines and suggest that further work should identify and remove barriers to accessing kidney transplantation among patients with moderate and severe obesity.
引用
- Wiebe N, Thompson S, Spellman A, et al. Access to Kidney Transplantation in Adults With Severe Obesity: A Population-Based Retrospective Cohort Study. Am J Kidney Dis. 2025. PMID: 41238158. doi:10.1053/j.ajkd.2025.09.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。